Skip to content

Honasa Consumer Limited (HONASA)

Large Cap

FMCG stocks · Large cap · NSE

Honasa Consumer Limited is an Indian BPC company that started with Mamaearth, a digital-first brand. It has expanded to 7 brands across 7 focus categories, leveraging a proprietary brand-building playbook and an omni-channel distribution strategy. The company aims to become India's largest pureplay BPC company.

₹441.15
-0.25 · -0.06%
Market cap ₹14,906 Cr
IndicesNifty 500
Data qualityFresh enough for analysisQuote updated 21 Oct, 03:31 pm IST
Details
Quote21 Oct, 03:31 pm IST
Base fundamentals14 Oct 2026 · screener
Latest result13 Aug, 03:45 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage14/14 · 100%
Valuation2026-07-20 · Rf 6.8% · FMCG P/E 37.8 (n=42)
Technical timing lens

Trend score and candlestick chart

33Bearish

SMA20 -3.2% / mo · MACD − · sector -5.7pp vs Nifty 500 (3M)

Stock trend: 46
Sector RS: 14
Sector 3M: -11.3% vs Nifty 500 -5.6%
FMCG FPI tailwindNot confirmed

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

HONASAD candles · FIT view+26.9%
Latest close ₹441.15 on 2026-10-21
Bar
-0.7%
RSI
41
MACD hist
-1.93
52W pos
74%
Visible chart range
Candle interval
2026-10-21O ₹444.05H ₹446.50L ₹435.55C ₹441.15Vol 3.7L sh
₹301.75₹356.24₹410.73₹465.22₹519.7152H₹441.152026-032026-06VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

HONASANifty FMCGNifty 500
-13%-4%+5%+14%21 Jul2 Sept21 Oct21 Oct 2026HONASA -2.2%Nifty FMCG -10.7%Nifty 500 -6.5%
HONASA
-2.2%
Nifty 500
-6.5%
Nifty FMCG
-10.7%
Vs Nifty 500
+4.3 pp
Chart stats
21 Oct 2026
From 52W high
-13.5%
₹509.8
52W range position
74%
₹248.4 - ₹509.8
ATR (14)
3.9%
₹17
Volume vs 20D
0.12x
Latest completed session
Avg traded value
₹140 Cr
20-session average
20D price channel
₹413.9 - ₹493
43.3% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is consistent.

Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · WATCHLIST
43

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Excellent
100

Revenue +27.1% · PAT +119.5% YoY

Technical
Bearish
33

Price trend and sector-relative-strength timing.

Valuation
Legacy model
-28.2%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
78

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 30 Jun 2026

Excellent · 100/100

Rev +27% YoY · PAT +120% YoY · margin expansion · +15% QoQ · operating leverage

Filed 13 Aug 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹756 Cr+27.1%+15.1%
EBITDA₹110 Cr+139.1%+42.9%
Operating margin15.0%+700 bps+300 bps
PAT₹90 Cr+119.5%+30.4%
PAT margin11.9%+501 bps+140 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
59.00
P/B
10.53
EV/EBITDA
43.72
Market Cap
14906.00Cr

Profitability

ROE
15.70%
ROCE
19.20%
ROA
11.82%
Dividend Y
0.66%

Growth (CAGR)

Revenue 5Y
39.00%
EPS 5Y
17.00%
Revenue 3Y
17.00%
EPS 3Y
42.50%

Balance Sheet

Debt/Equity
0.10
Interest Coverage
23.08×
Altman Z
8.64
Book Value
43.40

Cash Flow

FCF Yield
0.83%
FCF Positive Y
2/5
OCF
141.00 Cr
EPS TTM
7.65

Shareholding

Promoter Hold
35.47%
Promoter Pledge
0.00%
Momentum 52W
80%

Financial History

Updated 20/10/2026

Revenue

₹ Cr
Latest: 2,418+4.9% vs prev
02418Mar 2019: 17.0Mar 2020: 110Mar 2021: 460Mar 2022: 932Mar 2023: 1,395Mar 2024: 1,764Mar 2025: 2,305Mar 2026: 2,418FY19FY20FY21FY22FY23FY24FY25FY26

Net Profit

₹ Cr
Latest: 191+176.8% vs prev
-13320191.0Mar 2019: -4.0Mar 2020: -428Mar 2021: -1,332Mar 2022: 20.0Mar 2023: -121Mar 2024: 121Mar 2025: 69.0Mar 2026: 191FY19FY20FY21FY22FY23FY24FY25FY26

Return on Equity

%
Latest: 13.7+132.7% vs prev
-13.3013.7Mar 2019: -13.3%Mar 2022: 2.8%Mar 2024: 10.8%Mar 2025: 5.9%Mar 2026: 13.7%FY19FY20FY21FY22FY23FY24FY25FY26

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Bearish setup

Trend is weak — long-term uptrend intact. RSI 41.

  • Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
  • SMA20 falling (~3.3% over last month) — short-term momentum negative.
  • RSI(14) at 41 — falling, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 13% off 52W high · 78% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

94
RS percentile
Stage 2 UptrendEstablished S2
1M return
-6.9%
3M return
-2.2%
6M return
+27.5%
1Y return
+57.4%
RS 1D
0
RS 20D
0
Sector rank
#13
Industry rank
#18
Stage evidence
  • Price is 5.7% above the 30-week proxy.
  • The 50-DMA is above the 30-week proxy and its slope is rising +5.7%.
50-DMA
price below
200-DMA
price above
S2 entered
16 Apr 2026
S2 age
132 trading sessions
Sector
neutral
Industry
neutral
Relative-strength line vs Nifty 500 (base 100)
262 observations
21 Oct 2026Value 165.8+0.88%
84109133158182Sept 25Feb 26Jun 26Oct 26166
RS vs Nifty 500166

Valuation & peers

U-Score 43 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies

43U-SCORE
WATCHLIST

Fundamental score breakdown

U band · WATCHLIST
Valuation0/30
Growth15/25
Quality12/20
Balance Sheet9/15
Cash Flow2/10
Piotroski
8/9 (+5)
Penalties
0
Raw sum
43

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

43/100 · legacy band WATCHLIST

Positive drivers

  • Piotroski is strong at 8/9.
  • Growth contributes 15/25 to the score.
  • Quality contributes 12/20 to the score.

Main drags

  • Fair-value margin of safety is negative at -28.2%.
  • Valuation is weaker at 0/30; verify the latest quarterly trend.
  • Cash flow is weaker at 2/10; verify the latest quarterly trend.
Sector valuation model

Consumer valuation: PE/PEG and brand-quality premium

Consumer franchises can deserve higher multiples, but only when growth quality supports them.

Consumer PE/PEG
Primary lens
PE and PEG relative to growth, ROE, margins, and brand strength.
Secondary checks
Volume growth, pricing power, distribution, same-store or category growth.
Main risk check
Premium valuation needs durable growth and margin resilience.
PE
59.0
PB
10.5
EV/EBITDA
43.7
ROE
15.7%
ROCE
19.2%
FCF Yield
0.8%
Debt/Equity
0.1
MoS
-28.2%
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
43
Previous: 43
Legacy U-Score band
WATCHLIST
Previous: WATCHLIST
Margin of safety
-28.2%
Previous: -28.2%

Score history

12 stored score snapshots. Latest stored move: +0 points.

21 Oct 2026
v4.3-runtime-valuation
43
43
43
43
43
43
43
43
43
43
43
43

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹86.43
-410.4% MoS
Growth-justified P/E
45.0
Growth-justified Value
₹344.25
-28.2% MoS
PEG
2.17

Comparable companies

Peers

Business-comparable peers in FMCG — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
BIKAJI
Large
Bikaji Foods International Limited
FMCG
match 134
47
45.5
17.5%
-1%
FAIR VALUE
JYOTHYLAB
Micro
Jyothy Labs Limited
FMCG
match 124
49
24.2
21.7%
-1%
FAIR VALUE
BECTORFOOD
Micro
Mrs. Bectors Food Specialities Limited
FMCG
match 123
33
42.3
11.4%
+7%
WATCHLIST
HERITGFOOD
Micro
Heritage Foods Limited
FMCG
match 121
30
32.6
12.6%
-432%
OVERVALUED
EMAMILTD
Large
Emami Limited
Consumer Goods
match 119
62
21.8
26.2%
+50%
UNDERVALUED

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Where growth can come from, and what can break the case

Thesis intactReviewed 2026-06-15T03:23:24.724Z
Management commentary snapshot

Honasa reported FY26 revenue of ~INR 2,400 Cr, EBITDA of INR 230 Cr+, and PAT of ~INR 200 Cr, demonstrating strong financial performance and achieving double-digit growth across channels.

Management has successfully executed on prior commitments, including EBITDA margin expansion, Mamaearth's growth, and direct distribution enhancement. The company's FY26 results show robust growth and profitability, with a clear strategic roadmap for Honasa 2.0 focused on AI-led innovation, personalized communication, and expanded omni-channel distribution to achieve ambitious FY31 targets.

Current business mix

Revenue by Channel (FY26)

Latest issuer-disclosed distribution across 5 reported categories.

Businessmix
General Trade37.5%
Modern Trade22.5%
E-Commerce17.5%
Quick Commerce12.5%
Own Platform10.0%
Growth engines

Whitespace in BPC Categories

80+ partitions in the USD 20+ Bn Indian BPC market are yet to be entered by Honasa.

Omni-channel Distribution Expansion

Targeting 300k+ direct outlet reach by FY31, enabled by AI and automation.

AI-led Innovation & Communication

Agent OS and AI-driven tools for real-time platform spend optimization, dynamic media mix modeling, and faster product launches.

New Brand Building Playbook

New brands are designed for contribution margin neutrality by Year 2, leveraging partition additive entry and AI toolkits.

Capacity and execution

Direct Distribution Outlets

Direct distribution reach increased to ~120k outlets in FY26.

Direct Distribution Target

Targeting 300k+ direct outlet reach by FY31.

Tailwinds

Digital Media & E-commerce Growth

E-commerce & Quick Commerce penetration expected to reach ~40% channel salience by 2030.

Changing Media Landscape

Rise of OTT to 700M+ users and social media to 850M+ users, with Reels-first and vernacular content at scale.

Rise of Gen Z & Gen Alpha

Product-literate and authenticity-first customers will drive ~50% of the BPC market by 2030.

Rise of AI

Agentic AI replacing manual workflows, offering speed and quality improvements.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare YOY

The document presents annual financial results for FY26 and discusses a multi-year vision, making year-over-year comparison most relevant for assessing performance and future trajectory.

Sector KPIs management disclosed

Revenue from Operation

FY26 revenue from operation was ~INR 2,400 Cr.

EBITDA

FY26 EBITDA was INR 230 Cr+.

Profit After Tax

FY26 Profit After Tax was ~INR 200 Cr.

EBITDA Margin

FY26 EBITDA margin was 9.9%, up from ~7% in Q4FY24.

Management forward view

FY31 Revenue Target

Aims to become the fastest FMCG company in India to reach ₹5,000+ Cr revenue by FY31, targeting ₹5,500+ Cr.

FY31 EBITDA Target

Plans to achieve 15%+ EBITDA by FY31, unlocking 500 bps through improved channel mix, operating leverage, channel spend efficiencies, and changing category mix.

Brand Portfolio Growth

Mamaearth to reach ₹2,000+ Cr, The Derma Co to ₹1,500+ Cr, and at least two more brands to ₹500+ Cr by FY31.

Category Leadership

Aims to be a national market leader in at least two skincare categories and top 3 in two more by FY31.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Total Revenue~INR 2,400 Cr (FY26)Achieving ₹5,500+ Cr by FY31.
EBITDA Margin9.9% (FY26)Reaching 15%+ by FY31.
Direct Distribution Reach~120k outletsProgress towards 300k+ direct outlet reach by FY31.
Mamaearth RevenueBack to teens growthReaching ₹2,000+ Cr by FY31.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Trust Score
78Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 86th percentile of the scored universe and 50th percentile within FMCG. No major sub-score weakness stands out.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 21 Oct 2026
management-trust-v1
52 docs text-extracted · 22 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
86th percentile

overall median 67 · FMCG: 50th pctile, median 79 · Large: 70th pctile, median 73

Evidence depth
Financial-only

52 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
65
acceptable · profit to cash conversion
Balance sheet
96
strong · leverage and solvency
Discipline
76
strong · capital discipline
Results
77
strong · quarterly consistency

Trust positives

  • ▸Promoter pledge is zero.
  • ▸FCF yield is positive at 0.8%.
  • ▸Debt/equity is 0.10.
  • ▸4/4 latest quarters had positive YoY revenue growth.

Trust risks

  • ▸OPM spread across recent quarters is 22%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

12 shown
AnnouncementSep 2026

Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Sep - Honasa management to meet investors at Jefferies India Forum on September 17 and J.P. Morgan India Conference on September 22, 2026.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Sep

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Sep - Newspaper Publication for the Notice of 10th Annual General Meeting and E-Voting Information.

Source: Bse

Open source ↗
Investor presentationAug 2026

Aug 2026 · PPT

Source: Bse

Open source ↗
Concall transcriptAug 2026

Aug 2026 · Transcript

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Aug - Newspaper Publication for information regarding 10th Annual General Meeting and Record Date for Final Dividend

Source: Bse

Open source ↗
Concall transcriptJun 2026

Jun 2026 · Transcript

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Press Release / Media Release 23 Jun - Honasa acquires 58% stake in Fluence Pharma; launches Honasa Health for nutraceuticals.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Acquisition 23 Jun - Honasa to acquire 58% of Fluence Pharma for ~₹135 crore and form Honasa Health subsidiary.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 15 Jun - Allotment of 6,54,422 equity shares of face value of Rs. 10/- each upon exercise of vested stock options by employees

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Change in Management 21 May - Honasa reported FY26 revenue ₹23,919.42 million, PAT ₹2,001.90 million, and recommended ₹3 final dividend.

Source: Bse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.